0001365618-16-000008.txt : 20160415 0001365618-16-000008.hdr.sgml : 20160415 20160415211407 ACCESSION NUMBER: 0001365618-16-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160414 FILED AS OF DATE: 20160415 DATE AS OF CHANGE: 20160415 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc DATE OF NAME CHANGE: 20070830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hove Anders D CENTRAL INDEX KEY: 0001365618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 161575621 MAIL ADDRESS: STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508 CITY: NEW YORK STATE: NY ZIP: 10112 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-04-14 0001411158 Anacor Pharmaceuticals, Inc. ANAC 0001365618 Hove Anders D C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 1 0 0 0 Common Stock 2016-04-14 4 C 0 257647 31.05 A 353881 I By Funds and LLC's Common Stock 33886 D 2.00% Convertible Senior Notes due 2021 31.05 2016-04-14 4 C 0 8000000.00 0 D 2021-10-15 Common Stock 257647 0 I By Funds and LLC's The conversions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP"), VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), VHCP Co-Investment Holdings II, LLC ("VHCP Co-Invest II"), Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP") and Venrock Entreprenerus Fund IV, L.P. ("VEF4") on March 16, 2016. The shares are held as follows: 44,464 shares held by VA4, 9,068 shares held by VP, 1,092 shares held by VEF4, 100,521 shares held by VHCP, 18,383 shares held by VHCP Co-Invest, 151,658 shares held by VHCP II, and 28,695 shares held by VHCP Co-Invest II. Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. VHCP Management II, LLC ("VHCP Management II") is the general partner of VHCP II and the manager of VHCP Co-Invest II and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management and VHCP Management II. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VHCP II, VHCP Co-Invest II, VM4, VPM, VEFM4, VHCP Management and VHCP Management II except to the extent of his indirect pecuniary interest therein. The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold an aggregate of 794 of the reported securities for the sole benefit of the Management Company (the "Management Company Shares"). The Management Company may be deemed the indirect beneficial owner of the Management Company Shares, and the reporting person may be deemed the indirect beneficial owner of the Management Company Shares through his interest in the Management Company. The reporting person disclaims beneficial ownership of the Management Company Shares except to the extent of his indirect pecuniary interest therein. The 2.00% Convertible Senior Notes due 2021 were convertible into common stock at a conversion price equal to $31.05 (32.2061 shares of common stock for each $1,000 worth of principal) on the date of conversion. /s/ Anders D. Hove 2016-04-15